Patents by Inventor Michael S. Daniel

Michael S. Daniel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PIMOBENDAN FORMULATION AND METHOD OF USE THEREOF
    Publication number: 20240382478
    Abstract: Provided herein are chewable oral formulations including pimobendan for use in mammals to treat cardiac disorders.
    Type: Application
    Filed: July 26, 2024
    Publication date: November 21, 2024
    Inventors: Douglas I. Hepler, Michael S. Daniel, Neil E. Paulsen, Gail L. Dempsey
  • COMPOSITIONS COMPRISING A CONSTITUENT, DERIVATIVE OR EXTRACT OF CANNABIS
    Publication number: 20240325415
    Abstract: The present invention relates to compositions comprising active agents formulated for both buccal and gastric delivery wherein the composition also comprises one or more constituent, derivative or extract of cannabis and a further physiologically active agent.
    Type: Application
    Filed: July 21, 2022
    Publication date: October 3, 2024
    Inventors: Steven L ALDERMAN, Thomas POOLE, Karen TALUSKIE, Kathryn L WILBERDING, Jenni HAWKE, Ashley DAVIES, Michael S DANIEL, Kai TANG, Keyi XU, Karina MCQUILLAN, John CARAWAY
  • COMPOSITIONS COMPRISING A CONSTITUENT, DERIVATIVE OR EXTRACT OF CANNABIS
    Publication number: 20240316076
    Abstract: The present invention relates to compositions comprising one or more constituent, derivative or extract of cannabis formulated for gastric delivery and one or more flavour or sensate formulated for buccal delivery.
    Type: Application
    Filed: July 21, 2022
    Publication date: September 26, 2024
    Inventors: Steven L ALDERMAN, Karen TALUSKIE, Kathryn L WILBERDING, Jenni HAWKE, Ashley DAVIES, Thomas H POOLE, Michael S DANIEL, Kai TANG, Keyi XU, Karina MCQUILLAN, John CARAWAY
  • INJECTABLE ANTIBIOTIC FORMULATIONS AND USE THEREOF
    Publication number: 20240285662
    Abstract: Provided herein are pharmaceutically acceptable compositions containing macrolide antibiotics, in particular azithromycin. In particular, compositions containing azithromycin with low toxicity, especially for administration to felines, are provided herein.
    Type: Application
    Filed: May 1, 2024
    Publication date: August 29, 2024
    Inventors: Neil E. Paulsen, Gail L. Dempsey, Michael S. Daniel, Tiffany G. Tomlinson, Douglas I. Hepler, Raymond Petzold
  • LONG-ACTING INJECTABLE FORMULATIONS AND USE THEREOF
    Publication number: 20240245713
    Abstract: Provided herein are long-acting, non-aqueous pharmaceutically acceptable compositions of active ingredients for subcutaneous injection.
    Type: Application
    Filed: April 3, 2024
    Publication date: July 25, 2024
    Inventors: Gail L. Dempsey, Douglas I. Hepler, Dorothea Erxleben, Michael S. Daniel, Neil E. Paulsen
  • Injectable antibiotic formulations and use thereof
    Patent number: 12005071
    Abstract: Provided herein are pharmaceutically acceptable compositions containing macrolide antibiotics, in particular azithromycin. In particular, compositions containing azithromycin with low toxicity, especially for administration to felines, are provided herein.
    Type: Grant
    Filed: March 20, 2023
    Date of Patent: June 11, 2024
    Assignee: Dechra Veterinary Products, LLC
    Inventors: Neil E. Paulsen, Gail L. Dempsey, Michael S. Daniel, Tiffany G. Tomlinson, Douglas I. Hepler, Raymond Petzold
  • INJECTABLE ANTIBIOTIC FORMULATIONS AND USE THEREOF
    Publication number: 20230226091
    Abstract: Provided herein are pharmaceutically acceptable compositions containing macrolide antibiotics, in particular azithromycin. In particular, compositions containing azithromycin with low toxicity, especially for administration to felines, are provided herein.
    Type: Application
    Filed: March 20, 2023
    Publication date: July 20, 2023
    Inventors: Neil E. Paulsen, Gail L. Dempsey, Michael S. Daniel, Tiffany G. Tomlinson, Douglas I. Hepler, Raymond Petzold
  • ORAL PRODUCTS WITH NICOTINE-POLYMER COMPLEX
    Publication number: 20230148652
    Abstract: Products containing a nicotine-polymer complex are provided herein, which can optionally further include one or more, different nicotine components. Certain such products are pouched products including an outer water-permeable pouch defining a cavity containing a composition comprising a water-soluble component capable of being released through the water-permeable pouch. The disclosure further provides methods of preparing such products.
    Type: Application
    Filed: November 15, 2022
    Publication date: May 18, 2023
    Inventors: Shahin Roohinejad, Christopher Keller, Michael Andrew Zawadzki, Brandon Scott Darrow, Michael S. Daniel, Cortney R. Jackson, Joshua Lee Watts
  • Injectable antibiotic formulations and use thereof
    Patent number: 11628180
    Abstract: Provided herein are pharmaceutically acceptable compositions containing macrolide antibiotics, in particular azithromycin. In particular, compositions containing azithromycin with low toxicity, especially for administration to felines, are provided herein.
    Type: Grant
    Filed: March 10, 2021
    Date of Patent: April 18, 2023
    Assignee: Dechra Veterinary Products, LLC
    Inventors: Neil E. Paulsen, Gail L. Dempsey, Michael S. Daniel, Tiffany G. Tomlinson, Douglas I. Hepler, Raymond Petzold
  • EFFERVESCENT ORAL COMPOSITION
    Publication number: 20220347165
    Abstract: The disclosure provides a multi-layered tablet configured for oral use, the tablet including a first layer including an effervescent composition and a second layer including a non-effervescent composition. The effervescent composition includes an effervescent material; one or more fillers in a total amount of at least about 30% by weight, the one or more fillers including at least one sugar alcohol; and at least one active ingredient. The non-effervescent composition includes one or more fillers in a total amount of at least about 30% by weight, the one or more fillers including at least one sugar alcohol; a binder; and a second active ingredient.
    Type: Application
    Filed: April 22, 2022
    Publication date: November 3, 2022
    Inventors: MICHAEL S. DANIEL, STEVEN LEE ALDERMAN, ROSS JAY ODEN
  • ORAL PRODUCTS WITH SELF-EMULSIFYING SYSTEM
    Publication number: 20220287355
    Abstract: The disclosure provides solid products configured for oral use. The products contain a lipophilic active ingredient, a self-emulsifying delivery system (SEDS), a binder, and at least one sugar, at least one sugar alcohol, or a combination thereof. The SEDS is configured to provide droplets including the lipophilic active ingredient, the droplets have a D90 value in a range from about 10 to about 1000 nm.
    Type: Application
    Filed: March 11, 2022
    Publication date: September 15, 2022
    Inventors: MICHAEL S. DANIEL, THOMAS H. POOLE
  • INJECTABLE ANTIBIOTIC FORMULATIONS AND USE THEREOF
    Publication number: 20220031724
    Abstract: Provided herein are pharmaceutically acceptable compositions containing macrolide antibiotics, in particular azithromycin. In particular, compositions containing azithromycin with low toxicity, especially for administration to felines, are provided herein.
    Type: Application
    Filed: March 10, 2021
    Publication date: February 3, 2022
    Inventors: Neil E. Paulsen, Gail L. Dempsey, Michael S. Daniel, Tiffany G. Tomlinson, Douglas I. Hepler, Raymond Petzold
  • THERAPEUTIC FORMULATIONS AND USES THEREOF
    Publication number: 20210186923
    Abstract: Provided herein are pharmaceutically acceptable compositions containing a selective cyclooxygenase-2 (COX-2) inhibitor (coxib) and optionally buprenorphine. In particular, compositions containing a coxib formulated for oral, topical or subcutaneous administration to treat pain or inflammation are described.
    Type: Application
    Filed: October 29, 2020
    Publication date: June 24, 2021
    Inventors: Douglas I. Hepler, Gail L. Dempsey, Roland Johnson, Michael Kelly, Michael S. Daniel, Neil E. Paulsen, Bert Clayton
  • PIMOBENDAN FORMULATION AND METHOD OF USE THEREOF
    Publication number: 20210177842
    Abstract: Provided herein are chewable oral formulations including pimobendan for use in mammals to treat cardiac disorders.
    Type: Application
    Filed: October 23, 2020
    Publication date: June 17, 2021
    Inventors: Douglas I. Hepler, Michael S. Daniel, Neil E. Paulsen, Gail L. Dempsey
  • INJECTABLE ANTIBIOTIC FORMULATIONS AND USE THEREOF
    Publication number: 20210106602
    Abstract: Provided herein are pharmaceutically acceptable compositions containing macrolide antibiotics, in particular azithromycin and tulathromycin. In particular, compositions containing azithromycin or tulathromycin with low toxicity, especially for administration to canines, are provided herein.
    Type: Application
    Filed: May 22, 2020
    Publication date: April 15, 2021
    Inventors: Douglas I. Hepler, Neil E. Paulsen, Gail L. Dempsey, Michael S. Daniel, Tiffany G. Tomlinson
  • LONG-ACTING TOPICAL FORMULATION AND METHOD OF USE THEREOF
    Publication number: 20200390688
    Abstract: Provided herein are long-acting, non-aqueous pharmaceutically acceptable compositions of active ingredients for topical administration.
    Type: Application
    Filed: June 12, 2020
    Publication date: December 17, 2020
    Inventors: Douglas Hepler, Neil E. Paulsen, Michael S. Daniel, Gail L. Dempsey
  • LONG-ACTING INJECTABLE FORMULATIONS AND USE THEREOF
    Publication number: 20200368263
    Abstract: Provided herein are long-acting, non-aqueous pharmaceutically acceptable compositions of active ingredients for subcutaneous injection.
    Type: Application
    Filed: May 20, 2020
    Publication date: November 26, 2020
    Inventors: Gail L. Dempsey, Douglas L. Hepler, Dorothea Erxleben, Michael S. Daniel, Neil E. Paulsen
  • INJECTABLE ANTIBIOTIC FORMULATIONS AND USE THEREOF
    Publication number: 20200352971
    Abstract: Provided herein are pharmaceutically acceptable compositions containing macrolide antibiotics, in particular azithromycin. In particular, compositions containing azithromycin with low toxicity, especially for administration to felines, are provided herein.
    Type: Application
    Filed: July 23, 2020
    Publication date: November 12, 2020
    Inventors: Neil E. Paulsen, Gail L. Dempsey, Michael S. Daniel, Tiffany G. Tomlinson, Douglas Hepler, Raymond Petzold
  • Injectable antibiotic formulations and use thereof
    Patent number: 10729709
    Abstract: Provided herein are pharmaceutically acceptable compositions containing macrolide antibiotics, in particular azithromycin. In particular, compositions containing azithromycin with low toxicity, especially for administration to felines, are provided herein.
    Type: Grant
    Filed: March 20, 2019
    Date of Patent: August 4, 2020
    Assignee: Piedmont Animal Health Inc.
    Inventors: Neil E. Paulsen, Gail L. Dempsey, Michael S. Daniel, Tiffany G. Tomlinson, Douglas Hepler, Raymond Petzold
  • INJECTABLE ANTIBIOTIC FORMULATIONS AND USE THEREOF
    Publication number: 20190216836
    Abstract: Provided herein are pharmaceutically acceptable compositions containing macrolide antibiotics, in particular azithromycin. In particular, compositions containing azithromycin with low toxicity, especially for administration to felines, are provided herein.
    Type: Application
    Filed: March 20, 2019
    Publication date: July 18, 2019
    Inventors: Neil E. Paulsen, Gail L. Dempsey, Michael S. Daniel, Tiffany G. Tomlinson, Douglas Hepler, Raymond Petzold